You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-AIF antibody [7F7AB10] (ab110327)

MSCatalog No. MSA09

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-AIF antibody [7F7AB10]
See all AIF products (13) ...

Description

Mouse monoclonal [7F7AB10] to AIF

Tested applications

IHC-P, In-Cell ELISA, Flow Cyt, IP, WB, ICC/IFmore details

Cross reactivity

Reacts with

Human

Immunogen

Human heart mitochondria.

Positive control

Isolated mitochondria from Human heart; HeLa and HL60 cells. FFPE human heart tissue sections.

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

Preservative: 0.02% Sodium azide
Constituent: HBS

Concentration

Concentration information loading...

Purity

IgG fraction

Purification notes

ab110327 was produced in vitro using hybridomas grown in serum-free medium, and then purified by biochemical fractionation.

Clonality

Monoclonal

Clone number

7F7AB10

Isotype

IgG1

Light chain type

kappa

  • Western blot - AIF antibody [7F7AB10] (ab110327)Western blot - AIF antibody [7F7AB10] (ab110327) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - AIF antibody [7F7AB10] (ab110327)Immunocytochemistry/ Immunofluorescence - AIF antibody [7F7AB10] (ab110327) image (enlarge)

  • Flow Cytometry - AIF antibody [7F7AB10] (ab110327)Flow Cytometry - AIF antibody [7F7AB10] (ab110327) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab110327 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide1 Image

    IHC-P

     IHC-P: Use a concentrati...Read more →

    IHC-P: Use a concentration of 10 µg/ml. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  • ShowHide

    In-Cell ELISA

     In-Cell ELISA: Use at an...Read more →

    In-Cell ELISA: Use at an assay dependent concentration.

  • ShowHide1 Image

    Flow Cyt

     Flow Cyt: Use a concentr...Read more →

    Flow Cyt: Use a concentration of 1 µg/ml.

  • ShowHide

    IP

     IP: Use at an assay depe...Read more →

    IP: Use at an assay dependent dilution.

  • ShowHide1 Image

    WB

     WB: Use a concentration ...Read more →

    WB: Use a concentration of 2 - 5 µg/ml. Predicted molecular weight: 67 kDa.

  • ShowHide1 Image

    ICC/IF

     ICC/IF: Use a concentrat...Read more →

    ICC/IF: Use a concentration of 5 - 10 µg/ml. For 2 hours.Paraformaldehyde fixed (4%, 20 minutes) and Triton X-100 permeabilized (0.1%, 15 minutes).

Target

Function

Probable oxidoreductase that has a dual role in controlling cellular life and death; during apoptosis, it is translocated from the mitochondria to the nucleus to function as a proapoptotic factor in a caspase-independent pathway, while in normal mitochondria, it functions as an antiapoptotic factor via its oxidoreductase activity. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e., caspase-independent fragmentation of chromosomal DNA. Interacts with EIF3G,and thereby inhibits the EIF3 machinery and protein synthesis, and activates casapse-7 to amplify apoptosis. Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Binds to DNA in a sequence-independent manner.

Involvement in disease

Defects in AIFM1 are the cause of combined oxidative phosphorylation deficiency type 6 (COXPD6) [MIM:300816]. It is a mitochondrial disease resulting in a neurodegenerative disorder characterized by psychomotor delay, hypotonia, areflexia, muscle weakness and wasting.

Sequence similarities

Belongs to the FAD-dependent oxidoreductase family.

Post-translational
modifications

Under normal conditions, a 54-residue N-terminal segment is first proteolytically removed during or just after translocation into the mitochondrial intermembrane space (IMS) by the mitochondrial processing peptidase (MPP) to form the inner-membrane-anchored mature form (AIFmit). During apoptosis, it is further proteolytically processed at amino-acid position 101 leading to the generation of the mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis in a caspase-independent manner.

Cellular localization

Mitochondrion intermembrane space. Mitochondrion inner membrane. Cytoplasm. Nucleus. Cytoplasm > perinuclear region. Proteolytic cleavage during or just after translocation into the mitochondrial intermembrane space (IMS) results in the formation of an inner-membrane-anchored mature form (AIFmit). During apoptosis, further proteolytic processing leads to a mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis. Colocalizes with EIF3G in the nucleus and perinuclear region.

Target information above from: UniProt accessionO95831 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • mitochondrial antibody
  • AIFM1 antibody
  • AIFM1_HUMAN antibody
  • Apoptosis inducing factor 1, mitochondrial antibody
  • Apoptosis inducing factor antibody
  • Apoptosis inducing factor, mitochondrion associated, 1 antibody
  • Apoptosis-inducing factor 1 antibody
  • COXPD6 antibody
  • Harlequin antibody
  • Hq antibody
  • mAIF antibody
  • MGC111425 antibody
  • MGC5706 antibody
  • MSA09 antibody
  • PDCD 8 antibody
  • PDCD8 antibody
  • Programmed cell death 8 (apoptosis inducing factor) antibody
  • Programmed cell death 8 antibody
  • Programmed cell death 8 isoform 1 antibody
  • Programmed cell death 8 isoform 2 antibody
  • Programmed cell death 8 isoform 3 antibody
  • Programmed cell death protein 8 antibody
  • Programmed cell death protein 8 mitochondrial antibody
  • Programmed cell death protein 8 mitochondrial precursor antibody
  • Striatal apoptosis inducing factor antibody
see all

Anti-AIF antibody [7F7AB10] images:

  Western blot - AIF antibody [7F7AB10] (ab110327)

Western blot - AIF antibody [7F7AB10] (ab110327)

Anti-AIF antibody [7F7AB10] (ab110327) at 5 µg/ml + Isolated mitochondria from Human heart at 5 µg

Predicted band size : 67 kDa

  Immunocytochemistry/ Immunofluorescence - AIF antibody [7F7AB10] (ab110327)

Immunocytochemistry/ Immunofluorescence - AIF antibody [7F7AB10] (ab110327)

Immunocytochemistry analysis using ab110327 at 5µg/ml staining AIF in HeLa cells (4% paraformaldehyde fixed and Triton X-100 permeabilized). The secondary antibody was (green) Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1 hour. DAPI was used to stain the cell nuclei (blue). Target protein locates mainly in mitochondria.

  Flow Cytometry - AIF antibody [7F7AB10] (ab110327)

Flow Cytometry - AIF antibody [7F7AB10] (ab110327)

Flow cytometric analysis using ab110327 at 1µg/ml staining AIF in HL60 cells (blue). Isotype control antibody (red).

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AIF antibody [7F7AB10] (ab110327)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AIF antibody [7F7AB10] (ab110327)

IHC image of AIF staining in human heart formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab110327, 10µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References for Anti-AIF antibody [7F7AB10] (ab110327)

ab110327 has not yet been referenced specifically in any publications.

Publishing research using ab110327? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"